Systematic reviews are utilized in evidence-based medicine and are increasingly being used to help guide standards, guidelines, and clinical practice. The National Lung Screening Trial results prompted such a review of lung cancer screening literature. The review was endorsed by five major medical societies. We aimed at assessing its accuracy. Two independent groups of two reviewers reviewed the systematic review, including its source literature. Errors were placed into three major categories and tabulated: (i) selection of studies, (ii) misrepresentation of published reports, and (iii) errors in calculation and rounding. A total of 151 errors were found. There were 13 errors in selection of studies, 124 errors due to misrepresentation of published reports, and 14 errors in calculations and rounding. The extent of these errors raises concern about the credibility of the conclusions of the recent lung cancer screening systematic review. A process that allows for a thorough checking of data included in systematic reviews should be established.
aInstitute for Translational Epidemiology
bTisch Cancer Institute
cDepartment of Radiology, Mount Sinai School of Medicine, New York, New York, USA
dDepartment of Diagnostic Imaging, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
eInternational Prevention Research Institute, Lyon, France
All supplementary digital content is available directly from the corresponding author.
Correspondence to Rowena Yip, MPH, Institute for Translational Epidemiology, Mount Sinai School of Medicine, 1 Gustave Levy Place, New York, NY 10029, USA Tel: +1 212 241 2420; fax: +1 212 241 9655; e-mail: email@example.com
Received February 8, 2013
Accepted March 15, 2013